HealthDay - Dr. Douglas Dieterich: “Antiviral Therapy for Hepatitis C May Thwart Liver Cancer”

 – October 23, 2012 /Press Release/  –– 

Using antiviral drugs to treat patients with chronic hepatitis C infection may greatly reduce their risk of liver cancer, according to a new study. "This study confirms something that most of us who treat hepatitis C knew on a gut level but had never seen demonstrated so effectively," said Dr. Douglas Dieterich, professor of liver diseases at Mount Sinai School of Medicine in New York City. Liver cancer "is the fastest growing cancer in the U.S., so this gives us great hope that by treating hepatitis C, we can now not only cure the virus but prevent [liver cancer] in the future," he said. Learn more